A network meta-analysis evaluating the efficacy and safety of adjuvant therapy after nephrectomy in renal cell carcinoma
In the past few years, there has been a continuous rise in the occurrence of renal cell carcinoma (RCC), with RCC recurrence becoming the primary factor behind fatalities. Despite numerous clinical trials, the...
Source: BMC Urology - Category: Urology & Nephrology Authors: Lingyu Guo, Tian An, Zhixin Huang and Tie Chong Tags: Review Source Type: research
More News: Cancer & Oncology | Carcinoma | Clinical Trials | Kidney Cancer | Nephrectomy | Renal Cell Carcinoma | Urology & Nephrology